PNOĒ Launches Self-Administered Breath Testing Mask for Wellness Insights
PNOĒ, a Massachusetts-based company with operations in Greece, is set to launch its PNOĒ 2.0 mask on October 1. The device measures oxygen consumption and carbon dioxide exhalation during an eight-minute breathing test, providing users insights into their metabolism, fitness levels, and dietary needs. Unlike the previous version that required a trained operator, this new model allows self-administration, potentially expanding its use to gyms and pharmacies. The technology is rooted in metabolic testing used for over 100 years but has traditionally been limited due to bulky equipment found mainly in labs or hospitals. PNOĒ claims it offers the same accuracy with a portable device that delivers data on 23 biomarkers, including VO₂ max, resting metabolic rate, and metabolic flexibility. The company positions itself as part of the growing wellness industry rather than medical diagnostics, noting its devices are not FDA-cleared for clinical use. However, PNOĒ sees potential future applications in health monitoring based on breath data.
